This is positive feedback. The signal pulls more immune cells into the infected area, those cells release more of the same attractant signals, and the loop amplifies itself until the threat is cleared or the system is deliberately dampened. The response reinforces and magnifies the initial trigger rather than canceling it. That is the textbook definition of positive feedback, and chemotaxis-driven immune recruitment fits it precisely.

The mechanism: how a chemical whisper becomes a shout

Tissue-resident macrophages and mast cells sit in the dermis, mucosa, and organ linings as sentinels. When they detect pathogen-associated molecular patterns (PAMPs) such as bacterial lipopolysaccharide or viral double-stranded RNA, they release a burst of chemoattractants. The first responders are chemokines like CXCL8 (interleukin-8) and CCL2, plus complement fragment C5a and lipid mediators such as leukotriene B4.

These molecules diffuse outward and bind G-protein-coupled receptors on circulating neutrophils and monocytes. Receptor occupancy triggers actin polymerization and integrin activation, so the cell crawls up the chemical gradient toward the source. This directed migration is chemotaxis, and it is the physical bridge between signal and recruitment.

The recruited neutrophils do not just arrive; they degranulate and release more CXCL8 and more leukotriene B4. Each arriving cell becomes a new emitter. The gradient steepens, more cells are pulled in, and the local concentration of attractants climbs. That is the amplification step that makes the loop positive rather than merely responsive.

A useful way to hold the whole picture: one sentinel cell whispers, the first recruits repeat the whisper louder, and the crowd repeats it louder still. The signal grows with the response instead of shrinking it, which is exactly what positive feedback means in physiology.

Quantified context: how big does the amplification get?

Neutrophils are the most abundant white blood cells in circulation, roughly 4,000 to 11,000 per microliter in a healthy adult. A focused infection can mobilize a large fraction of that pool within hours, which is why blood neutrophil counts can rise sharply during acute bacterial infection.

Chemokine signaling operates at very low concentrations. CXCL8 can begin to engage its receptors in the nanomolar range, and leukotriene B4 is active at sub-nanomolar levels. The system is built for sensitivity, not brute force, which is why small initial signals can recruit disproportionate numbers of cells.

Migration speed matters too. Neutrophils can move through tissue at tens of micrometers per minute, so cells can traverse meaningful distances toward a focus within tens of minutes to a couple of hours. The arrival rate itself feeds the loop: faster arrivals mean faster signal reinforcement.

The amplification is bounded, and that bound is the point. Without braking, an unrestricted chemokine loop would recruit cells indefinitely. The body caps it through receptor desensitization, signal degradation, and regulatory cells, which is why the response self-limits once the pathogen is contained.

Timeline: from sentinel detection to resolution

Phase Approximate timing Dominant events
Sentinel activation Minutes Macrophages and mast cells detect PAMPs and release early chemokines
First wave arrival 1-4 hours Neutrophils follow CXCL8 and C5a gradients into tissue
Amplification peak 6-24 hours Recruited cells release more attractants; influx accelerates
Monocyte influx 12-48 hours CCL2 recruits monocytes that mature into macrophages
Adaptive handoff 3-7 days Dendritic cells present antigen; T and B cells expand
Resolution Days to weeks Attractant production falls; neutrophil apoptosis and clearance dominate

The table shows why the answer depends on which phase you inspect. Amplification is strongly positive early, then the system shifts toward damping as the threat declines. The positive loop is not the whole story; it is the opening act.

Edge cases and the counterintuitive detail

The most counterintuitive fact is that positive feedback here is protective, not pathological. In most engineering contexts positive feedback means runaway instability. In immunity, transient amplification is the intended design because it shortens the time to control a replicating pathogen.

Pathology arises when the loop fails to brake, not when it starts. Persistent chemokine production, defective clearance of apoptotic neutrophils, or unchecked complement activation can convert useful amplification into collateral tissue damage. That is the mechanism behind conditions like acute respiratory distress syndrome and severe sepsis-associated organ injury.

Another edge case is the site of recruitment. A localized skin abscess shows the loop in its cleanest form: a walled-off focus with a steep gradient and brisk neutrophil influx. A bloodstream infection has no fixed gradient, so systemic cytokine release can trigger broad endothelial activation rather than directed recruitment.

Some pathogens hijack the loop. Certain bacteria manipulate chemokine receptors or degrade chemoattractants to blunt recruitment, while others exploit the inflammatory influx as a nutrient source. The feedback loop is a battleground, not a fixed circuit.

Finally, the classification itself is context-dependent. A single snapshot of chemokine signaling looks like positive feedback. The full infection-to-resolution arc contains both positive and negative feedback phases. Calling the whole response "positive feedback" is accurate for the recruitment step and incomplete for the arc.

Red flag: fever above 103 F (39.4 C) with confusion, rapid breathing, or a racing heart can signal sepsis and needs emergency care. Red flag: a spreading skin infection with streaks, severe pain out of proportion to appearance, or skin that turns dusky warrants urgent evaluation. Red flag: infection in an immunocompromised person can progress without the usual robust inflammatory signs. Red flag: symptoms that worsen after 48-72 hours of appropriate care suggest the amplification loop is not being controlled.

Misconceptions and how the terminology trips people up

The most common error is treating positive feedback as synonymous with "good" and negative feedback as "bad." The terms describe direction of change, not desirability. Positive feedback amplifies a deviation; negative feedback reduces it. A fever climbing during infection is amplification, and it can be either helpful or harmful depending on magnitude.

A second misconception is that immune recruitment is one signal. In reality it is a redundant network of chemokines, complement fragments, lipid mediators, and cytokines. Redundancy makes the loop robust but also harder to classify cleanly, because different branches reinforce at different rates.

A third error is confusing chemotaxis with random inflammation. Chemotaxis is directional and gradient-dependent. If the gradient collapses, cells move randomly and recruitment becomes inefficient, which is one reason severe systemic inflammation looks chaotic rather than focused.

Textbook framing also hides the braking layer. Educators often present the recruitment cascade as pure amplification and leave negative regulation for a later chapter. The result is a mental model where the loop has no off switch. In reality, negative feedback is embedded at every level, from receptor internalization to anti-inflammatory cytokine release.

Comparison: positive versus negative feedback in immune signaling

Feature Positive feedback (recruitment loop) Negative feedback (resolution loop)
Trigger direction Amplifies the initial deviation Counteracts the initial deviation
Example signal CXCL8 recruiting more neutrophils IL-10 suppressing pro-inflammatory cytokine release
Timescale Minutes to hours Hours to days
Purpose Rapid containment of a replicating threat Prevent collateral damage and restore baseline
Failure mode Unchecked inflammation and tissue injury Persistent infection or immune paralysis
Clinical signature Rising neutrophil influx, escalating local inflammation Falling attractants, neutrophil apoptosis, macrophage cleanup
Textbook label Amplification cascade Regulatory brake

The comparison clarifies the answer. The chemokine recruitment step is the positive-feedback arm of a larger control system that also contains substantial negative feedback.

Practical actions and thresholds

For a person with a suspected infection, the useful action is not to classify the feedback loop but to recognize when amplification is exceeding useful bounds. The following steps are general and not a substitute for professional care.

Watch the trajectory rather than a single reading. A fever that peaks and begins to fall within 48-72 hours of supportive care is behaving as expected. A fever that climbs steadily past that window deserves clinical assessment.

Track mental status, breathing, and hydration alongside temperature. Confusion, labored breathing, or inability to keep fluids down are more informative than the number on the thermometer.

Use local guidance for when to seek care. General thresholds often cited include temperature above 100.4 F (38 C) with worsening symptoms, or any fever in an infant under 3 months. Reconcile conflicting thresholds by following the most conservative one for vulnerable groups: infants, older adults, pregnant people, and immunocompromised individuals.

Do not suppress fever routinely without guidance. Fever is part of the amplified response, and blanket suppression can mask the trajectory clinicians use to judge severity.

Keep the infection site clean and monitored. For skin infections, mark the edge of redness and recheck it every few hours; expansion despite care is a signal to escalate.

Limitations and what this explanation cannot settle

The positive-versus-negative classification is clean for the recruitment step and murky for the whole response. Any answer that treats immune feedback as one fixed category is oversimplifying a system that runs both loops simultaneously at different timescales.

The timing ranges in the timeline table are typical, not universal. Immune kinetics vary with pathogen type, inoculum size, host genetics, age, and prior exposure. Individual trajectories can differ substantially from the aggregate pattern.

This article describes stable physiological mechanisms and deliberately omits changing clinical recommendations, drug dosing, and dated statistics that would require current verified sources. It is general educational information, not a diagnosis or treatment plan. For any suspected infection, especially with warning signs, consult a qualified local clinician or emergency service.